These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 38869976)
1. Treatment for dry age-related macular degeneration: where we stand in 2024. Wheeler S; Mahmoudzadeh R; Randolph J Curr Opin Ophthalmol; 2024 Jun; ():. PubMed ID: 38869976 [TBL] [Abstract][Full Text] [Related]
2. Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration. Khan H; Aziz AA; Sulahria H; Khan H; Ahmed A; Choudhry N; Narayanan R; Danzig C; Khanani AM Clin Ophthalmol; 2023; 17():321-327. PubMed ID: 36741078 [TBL] [Abstract][Full Text] [Related]
3. Treatment of dry age-related macular degeneration: A review. Girgis S; Lee LR Clin Exp Ophthalmol; 2023 Nov; 51(8):835-852. PubMed ID: 37737509 [TBL] [Abstract][Full Text] [Related]
4. Advancements in Imaging and Therapeutic Options for Dry Age-Related Macular Degeneration and Geographic Atrophy. Servillo A; Sacconi R; Oldoni G; Barlocci E; Tombolini B; Battista M; Fantaguzzi F; Rissotto F; Mularoni C; Parravano M; Zucchiatti I; Querques L; Bandello F; Querques G Ophthalmol Ther; 2024 Aug; 13(8):2067-2082. PubMed ID: 38833127 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Options Under Development for Nonneovascular Age-Related Macular Degeneration and Geographic Atrophy. Kim JB; Lad EM Drugs Aging; 2021 Jan; 38(1):17-27. PubMed ID: 33355716 [TBL] [Abstract][Full Text] [Related]
6. Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration. Akyol E; Lotery A Biologics; 2020; 14():83-94. PubMed ID: 32982165 [TBL] [Abstract][Full Text] [Related]
7. Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions. Cabral de Guimaraes TA; Daich Varela M; Georgiou M; Michaelides M Br J Ophthalmol; 2022 Mar; 106(3):297-304. PubMed ID: 33741584 [TBL] [Abstract][Full Text] [Related]
8. Stem cell-based therapies for age-related macular degeneration: current status and prospects. Mu Y; Zhao M; Su G Int J Clin Exp Med; 2014; 7(11):3843-52. PubMed ID: 25550892 [TBL] [Abstract][Full Text] [Related]
9. A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration. Halawa OA; Lin JB; Miller JW; Vavvas DG J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34208067 [TBL] [Abstract][Full Text] [Related]
10. A Clinical and Preclinical Assessment of Clinical Trials for Dry Age-Related Macular Degeneration. Abidi M; Karrer E; Csaky K; Handa JT Ophthalmol Sci; 2022 Dec; 2(4):100213. PubMed ID: 36570624 [TBL] [Abstract][Full Text] [Related]
11. Current therapeutic developments in atrophic age-related macular degeneration. Hanus J; Zhao F; Wang S Br J Ophthalmol; 2016 Jan; 100(1):122-7. PubMed ID: 26553922 [TBL] [Abstract][Full Text] [Related]
12. The Role of Inflammation in Age-Related Macular Degeneration-Therapeutic Landscapes in Geographic Atrophy. Borchert GA; Shamsnajafabadi H; Hu ML; De Silva SR; Downes SM; MacLaren RE; Xue K; Cehajic-Kapetanovic J Cells; 2023 Aug; 12(16):. PubMed ID: 37626902 [TBL] [Abstract][Full Text] [Related]